ClinConnect ClinConnect Logo
Search / Trial NCT04665180

Determinants for Return to Work After Primary Knee Arthroplasty

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Dec 9, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how different factors affect a person's ability to return to work after having knee surgery called knee arthroplasty, which is often done for severe knee problems like osteoarthritis. The researchers want to find out how many patients go back to work and how long it takes them to do so after their surgery. They will also look at what influences their ability to return to work and how their need for pain medication changes before and after the operation. Additionally, they plan to ask participants some questions about returning to sports after their recovery.

To be eligible for this trial, you need to be 63 years old or younger, have had the knee surgery (either total or partial), and have been working for at least two years before your surgery. If you meet these criteria and are interested, you can expect to answer questionnaires about your work and activity levels. The trial is currently looking for participants, and everyone, regardless of gender, can join. This study aims to help understand how to better support people in returning to their jobs after knee surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Informed consent
  • Primary knee arthroplasty (total + unicondylar)
  • Patients younger than or equal to 63 years old at the time of surgery
  • Actively been working 2 year prior to surgery.
  • Exclusion Criteria:
  • No informed consent
  • Revision surgery
  • Patients older than 63 years of age at the time of surgery
  • Patients who haven't were unable to work due to other, non-knee related, health issues

About Universitaire Ziekenhuizen Ku Leuven

Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.

Locations

Leuven, Vlaams Brabant, Belgium

Patients applied

0 patients applied

Trial Officials

Hilde Vandenneucker

Principal Investigator

Universitaire Ziekenhuizen KU Leuven

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials